When to use a combination of dapaglifozin (10)and metformin 500 in a patient who is hypertensive well controlled (120/80) with telmisartan 20 female patient and now in a metformin 1000 therapy night dose . What are the rationale to start the dapa and metformin combination and what to check before administering it . Doesn't dapaglifozin cause euglycemic dka and risk of uti ?
I'll start with a quick preliminary answer, then consult the medical library and latest evidence in parallel.
Quick answer: Dapagliflozin + metformin combination is rational when metformin monotherapy is insufficient for glycemic control in T2DM, especially in patients with cardiovascular/renal benefit profiles. Before starting, check eGFR (must be ≥45 mL/min/1.73m²), baseline HbA1c, and genital hygiene status. Yes - euglycemic DKA and UTI are real risks with SGLT2 inhibitors, requiring patient education and vigilance.
Searching sources...
Reading File
Searching PubMed
dapagliflozin metformin combination type 2 diabetes
Searching PubMed
SGLT2 inhibitor euglycemic DKA UTI risk
You've run out of free credits. Sign up for a free account to continue using Orris.
This is a shared conversation. Sign in to Orris to start your own chat.